HIV-positive TB patients on ART (antiretroviral therapy) in Europe (WHO region)
Europe (WHO region): HIV-positive TB patients on ART (antiretroviral therapy) was 84.0% in 2024. ▲ Rising
HIV-positive TB patients on ART (antiretroviral therapy) in Europe (WHO region), 2004–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in Europe (WHO region) is 84.0%, measured in 2024.
Compared with earlier readings it is up 2.4% on the previous year and up 44.8% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Europe (WHO region) peaked at 100.0% in 2004 and was at its lowest, 25.0%, in 2005.
The long-run direction has been consistently rising across the 21 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2004 | 100.0% | — |
| 2005 | 25.0% | -75.0% |
| 2006 | 45.0% | +80.0% |
| 2007 | 28.0% | -37.8% |
| 2008 | 32.0% | +14.3% |
| 2009 | 60.0% | +87.5% |
| 2010 | 61.0% | +1.7% |
| 2011 | 58.0% | -4.9% |
| 2012 | 63.0% | +8.6% |
| 2013 | 54.0% | -14.3% |
| 2014 | 58.0% | +7.4% |
| 2015 | 63.0% | +8.6% |
| 2016 | 66.0% | +4.8% |
| 2017 | 68.0% | +3.0% |
| 2018 | 73.0% | +7.4% |
| 2019 | 76.0% | +4.1% |
| 2020 | 74.0% | -2.6% |
| 2021 | 80.0% | +8.1% |
| 2022 | 81.0% | +1.2% |
| 2023 | 82.0% | +1.2% |
| 2024 | 84.0% | +2.4% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in Europe (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +87.5% | 32.0% | 60.0% |
| 2005 | -75.0% | 100.0% | 25.0% |
| 2006 | +80.0% | 25.0% | 45.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.3% | 25.0% | 100.0% | 6 |
| 2010s | 64.0% | 54.0% | 76.0% | 10 |
| 2020s | 80.2% | 74.0% | 84.0% | 5 |
More health data for Europe (WHO region)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Number of under-five deaths, annual growth rate -8.58 % change on previous year (2024)
- Number of infant deaths, annual growth rate -5.46 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Europe (WHO region)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Europe (WHO region) was 84.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Europe (WHO region)?
- The highest recorded value was 100.0% in 2004.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Europe (WHO region)?
- The lowest recorded value was 25.0% in 2005.
- How does Europe (WHO region) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Europe (WHO region) ranks 7th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Europe (WHO region)?
- Over the last ten years it is up 44.8%. The long-run trend across the full record is rising.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).